Published in Lab Law Weekly, November 18th, 2005
At the first endoscopic evaluation, nearly half of patients who received maintenance therapy of Remicade every 8 weeks experienced complete healing, compared to only 37% of patients who were treated episodically. Additionally, complete healing in the maintenance therapy group was experienced long-term by more than half of patients after a median follow-up of 54 weeks, while no patients treated episodically...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.